Notice of Intent to Sole Source: Surveillance based Lyme Disease Network
Closed Special Notice Posted
- Solicitation number
- 75D30124R72992
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Danville, Pennsylvania, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) has issued a Special Notice indicating their intent to award a sole source firm fixed price purchase order to Geisinger Clinic for the Surveillance Based Lyme Disease Network. This is a follow-on contract to continue the services Geisinger Clinic has been providing under the current contract.
The purpose of this Special Notice is to inform interested parties that the CDC has determined Geisinger Clinic is the only responsible source that can satisfy the agency's requirements to develop, finalize, and implement Electronic Health Record (EHR) algorithms for estimating Lyme Disease (LD) incidence and outcomes, as well as monitor LD epidemiology trends. The significant start-up efforts, experience, and knowledge sharing required have already been established under the current contract. Interested parties may submit responses by 12:00 PM EST on May 29, 2024, but this is not a request for competitive quotes, and the CDC has sole discretion in determining whether to compete the proposed contract.
Notice text
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Geisinger Clinic for Surveillance Based Lyme Disease Network as a follow-on contract to 75D30123C18193. Geisinger is required to provide continued services to develop, finalize, and implement Electronic Health Record (HER) algorithms to provide estimates of Lyme Disease (LD) incidence and LD outcomes, and to monitor trends in LD epidemiology. Only one responsible source and no other services will satisfy agency requirements, as the start-up efforts, in terms of time, experience, and knowledge sharing, for all network participants have been significant and any contract awarded to other vendors would result in a loss of work and current data already collected. We therefore conclude that the only vendor option for the service contract is Geisinger Clinic. This contract action is for services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302-1. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at msipin@cdc.gov by 12:00 PM EST on 29 May 2024.
Files
| File | Type | Posted |
|---|---|---|
| JA_Geisinger Final 14 May 2024.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity